The Pickens Plan - One Year Later

Eric Marshall, of Hodges Capital Management, shares his favorite small cap plays.

Novartis is opening on Tuesday the country's first plant to produce flu vaccines using cell cultures. These vaccines are faster, better and cheaper to make than egg-based methods, reports CNBC's Mike Huckman.

Novartis is opening on Tuesday the country's first plant to produce flu vaccines using cell cultures. These vaccines are faster, better and cheaper to make than egg-based methods, reports CNBC's Mike Huckman.

Stuart Schweitzer, global market strategist at JPMorgan Private Bank, shares his global market outlook with CNBC.